223 related articles for article (PubMed ID: 12901595)
21. [Perspectives on recombinant live vaccines].
Ishii K
Nihon Rinsho; 2008 Oct; 66(10):1903-7. PubMed ID: 18939488
[TBL] [Abstract][Full Text] [Related]
22. Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge.
Wang Q; Li J; Zhang X; Liu Q; Liu C; Ma G; Cao L; Gong P; Cai Y; Zhang G
Vet Parasitol; 2009 Mar; 160(3-4):198-203. PubMed ID: 19117681
[TBL] [Abstract][Full Text] [Related]
23. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
Dietrich G; Spreng S; Gentschev I; Goebel W
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
[TBL] [Abstract][Full Text] [Related]
24. Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery.
Attridge SR; Vindurampulle CJ
Microb Pathog; 2005; 39(1-2):1-7. PubMed ID: 16002258
[TBL] [Abstract][Full Text] [Related]
25. Bacteriophages as tools for vaccine development.
Hatfull GF; Barsom L; Chang L; Donnelly-Wu M; Lee MH; Levin M; Nesbit C; Sarkis GJ
Dev Biol Stand; 1994; 82():43-7. PubMed ID: 7958482
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
[TBL] [Abstract][Full Text] [Related]
27. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
28. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
29. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
Singh R; Paterson Y
Expert Rev Vaccines; 2006 Aug; 5(4):541-52. PubMed ID: 16989634
[TBL] [Abstract][Full Text] [Related]
30. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
[TBL] [Abstract][Full Text] [Related]
31. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
Spreng S; Viret JF
Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
[TBL] [Abstract][Full Text] [Related]
32. Elicitation of predictable immune responses by using live bacterial vectors.
Drabner B; Guzmán CA
Biomol Eng; 2001 Mar; 17(3):75-82. PubMed ID: 11222981
[TBL] [Abstract][Full Text] [Related]
33. [Strategies for the development of new tuberculosis vaccines].
Fattorini L
Minerva Med; 2007 Apr; 98(2):109-19. PubMed ID: 17519853
[TBL] [Abstract][Full Text] [Related]
34. Listeria monocytogenes as an alternative vaccine vector for HIV.
Mata M; Paterson Y
Arch Immunol Ther Exp (Warsz); 2000; 48(3):151-62. PubMed ID: 10912619
[TBL] [Abstract][Full Text] [Related]
35. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
Medina E; Guzmán CA
Vaccine; 2001 Feb; 19(13-14):1573-80. PubMed ID: 11166877
[TBL] [Abstract][Full Text] [Related]
36. Rational design of Salmonella-based vaccination strategies.
Spreng S; Dietrich G; Weidinger G
Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
[TBL] [Abstract][Full Text] [Related]
37. [Listeria monocytogenes: a dangerous pathogen used as a vector for the new generation of vaccines].
Tkachuk MV; Iarovinskiĭ FO; Tonevitskiĭ AG
Vopr Med Khim; 2000; 46(3):256-64. PubMed ID: 11033885
[TBL] [Abstract][Full Text] [Related]
38. Listeria as a vaccine vector.
Bruhn KW; Craft N; Miller JF
Microbes Infect; 2007 Aug; 9(10):1226-35. PubMed ID: 17719258
[TBL] [Abstract][Full Text] [Related]
39. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
Lewis GK
Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
[TBL] [Abstract][Full Text] [Related]
40. Transformation of BCG with plasmid DNA.
Lugosi L; Jacobs W; Bloom BR
Acta Leprol; 1989; 7 Suppl 1():256-7. PubMed ID: 2503999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]